Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Public ClinicalTrials.gov record NCT05063994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Active-Controlled, Phase 3 Study of Chronocort Compared With Immediate-Release Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Study identification
- NCT ID
- NCT05063994
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Neurocrine UK Limited
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Chronocort Drug
- Cortef Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2022
- Primary completion
- Feb 1, 2024
- Completion
- Feb 1, 2024
- Last update posted
- Feb 24, 2025
2022 – 2024
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diurnal Investigational Site in Los Angeles | Los Angeles | California | 90027 | — |
| Diurnal Investigational Site in Orange | Orange | California | 92868 | — |
| Diurnal Investigational Site in Jacksonville | Jacksonville | Florida | 32207 | — |
| Diurnal Investigational Site in Iowa | Iowa City | Iowa | 52224 | — |
| Diurnal Investigational Site in Maryland | Bethesda | Maryland | 20892-1932 | — |
| Diurnal Investigational Site in Michigan | Ann Arbor | Michigan | 48109 | — |
| Diurnal Investigational Site in Rochester | Rochester | Minnesota | 55901 | — |
| Diurnal Investigational Site in Nevada | Las Vegas | Nevada | 89148 | — |
| Diurnal Investigational Site in Dallas | Dallas | Texas | 75235 | — |
| Diurnal Investigational Site in Seattle | Seattle | Washington | 98105 | — |
| Diurnal Investigational Site in Milwaukee | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05063994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05063994 live on ClinicalTrials.gov.